These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy-associated venous thromboembolism. Cox S; Eslick R; McLintock C J Thromb Haemost; 2019 Jul; 17(7):1160-1170. PubMed ID: 31013386 [TBL] [Abstract][Full Text] [Related]
7. Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study. Blondon M; Lansiaux M; Bryan S; Dongala A; Pavoncello R; Chatellier G; Claver M; Azria E; Martinez de Tejada B; Hugon-Rodin J J Thromb Haemost; 2024 Oct; 22(10):2834-2843. PubMed ID: 38972385 [TBL] [Abstract][Full Text] [Related]
8. The incidence and risk factors of recurrent venous thromboembolism during pregnancy. Galambosi PJ; Ulander VM; Kaaja RJ Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671 [TBL] [Abstract][Full Text] [Related]
9. A Longitudinal Study of Thrombosis and Bleeding Outcomes With Thromboprophylaxis in Pregnant Women at Intermediate and High Risk of VTE. Schapkaitz E; Libhaber E; Gerber A; Rhemtula H; Zamparini J; Jacobson BF; Büller HR Clin Appl Thromb Hemost; 2023; 29():10760296231160748. PubMed ID: 36972476 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer. Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498 [TBL] [Abstract][Full Text] [Related]
12. Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective? Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S J Thromb Haemost; 2011 Mar; 9(3):473-80. PubMed ID: 21232006 [TBL] [Abstract][Full Text] [Related]
13. Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice. den Exter PL; Hooijer J; van der Hulle T; van Oosten JP; Dekkers OM; Klok FA; Huisman MV Thromb Haemost; 2017 Nov; 117(11):2163-2167. PubMed ID: 28981552 [TBL] [Abstract][Full Text] [Related]
14. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study. Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493 [TBL] [Abstract][Full Text] [Related]
15. Association between prophylactic low-molecular-weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort. Lowry DE; Corsi DJ; White RR; Guo M; Lanes A; Smith G; Rodger M; Wen SW; Walker M; Gaudet L J Thromb Haemost; 2019 Feb; 17(2):345-349. PubMed ID: 30552749 [TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in pregnancy: diagnosis, management and prevention. Chunilal SD; Bates SM Thromb Haemost; 2009 Mar; 101(3):428-38. PubMed ID: 19277402 [TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial. Rodger MA; Phillips P; Kahn SR; James AH; Konkle BA; Thromb Haemost; 2015 Jan; 113(1):212-6. PubMed ID: 25373438 [TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in pregnancy. Marik PE Clin Chest Med; 2010 Dec; 31(4):731-40. PubMed ID: 21047579 [TBL] [Abstract][Full Text] [Related]
19. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy. Ní Ainle F; Wong A; Appleby N; Byrne B; Regan C; Hassan T; Milner M; Sullivan AO; White B; O'Donnell J Blood Coagul Fibrinolysis; 2008 Oct; 19(7):689-92. PubMed ID: 18832911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]